An Open-Label Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Trial Profile

An Open-Label Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2014

At a glance

  • Drugs Droxidopa (Primary)
  • Indications Chronic fatigue syndrome; Orthostatic hypotension
  • Focus Therapeutic Use
  • Sponsors Chelsea Therapeutics
  • Most Recent Events

    • 24 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top